Phost'in Therapeutics
Discovering Glycocalyx Modifiers for Cancer
- B2B
About Phost'in Therapeutics
Innovative biotech company developing Glycocalyx Modifiers to selectively treat cancers and other serious diseases by targeting a key immune-suppressing mechanism
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Montpellier, Occitanie, France
- Revenue
- $5.9M – $46.6MTamtam estimate
- Website
- phostin.com
Phost'in Therapeutics at a glance
Phost'in Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Montpellier, Occitanie, France.
Phost'in Therapeutics has 11–50 employees.
Phost'in Therapeutics's revenue is $5.9M – $46.6M (Tamtam estimate).
Selling to companies like Phost'in Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies